Natural health product · NPN 80105228
Prosta Shield
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed October 14, 2020.
- Natural Product Number (NPN)
- 80105228
- Licence holder
- Rapha Canadian Natural
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- General (non-traditional)
- First licensed
- October 14, 2020
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Urtica dioica | 50 mg | Root; 5.0:1.0 Dry; equivalent to 250.0 mg dried herb |
| Vitamin D | 2.5 mcg | Cholecalciferol |
| Zinc | 7.5 mg | Zinc citrate |
| Lycopene | 375 mcg | Lycopene |
| Lepidium meyenii | 150 mg | Root; 6.0:1.0 Dry; equivalent to 900.0 mg dried herb |
| Prunus africana | 10 mg | Trunk bark; 4.0:1.0 Dry; equivalent to 40.0 mg dried herb |
| Ginkgo biloba | 50 mg | Leaf; 6 % Terpene lactones; 50.0:1.0 Dry; equivalent to 2500.0 mg dried herb |
| Ginkgo biloba | — | Leaf; 24 % Flavonoid glycosides |
| Phytosterols | 25 mg | Glycine max - Seed |
| Panax ginseng | 30 mg | Root; 5 % Total ginsenosides; 8.0:1.0 Dry; equivalent to 240.0 mg dried herb |
| Serenoa repens | 180 mg | Fruit; 10.0:1.0 Dry; equivalent to 1800.0 mg dried herb |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow/ incomplete voiding/frequent daytime /night time urination) associated with mild to moderate benign prostatic hyperplasia (BPH).
Non-medicinal ingredients
Hypromellose; Magnesium stearate; Microcrystalline cellulose